Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer

Abstract

Background: Numerous studies have shown that infiltrating eosinophils play a key role in the tumor progression of bladder urothelial carcinoma (BLCA). However, the roles of eosinophils and associated hub genes in clinical outcomes and immunotherapy are not well known.Methods: BLCA patient data were extracted from the TCGA database. The tumor immune microenvironment (TIME) was revealed by the CIBERSORT algorithm. Candidate modules and hub genes associated with eosinophils were identified by weighted gene co-expression network analysis (WGCNA). The external GEO database was applied to validate the above results. TIME-related genes with prognostic significance were screened by univariate Cox regression analysis, lasso regression, and multivariate Cox regression analysis. The patient’s risk score (RS) was calculated and divided subjects into high-risk group (HRG) and low-risk group (LRG). The nomogram was developed based on the risk signature. Models were validated via receiver operating characteristic (ROC) curves and calibration curves. Differences between HRG and LRG in clinical features and tumor mutational burden (TMB) were compared. The Immune Phenomenon Score (IPS) was calculated to estimate the immunotherapeutic significance of RS. Half-maximal inhibitory concentrations (IC50s) of chemotherapeutic drugs were predicted by the pRRophetic algorithm.Results: 313 eosinophil-related genes were identified by WGCNA. Subsequently, a risk signature containing 9 eosinophil-related genes (AGXT, B3GALT2, CCDC62, CLEC1B, CLEC2D, CYP19A1, DNM3, SLC5A9, SLC26A8) was finally developed via multiplex analysis and screening. Age (p < 0.001), grade (p < 0.001), and RS (p < 0.001) were independent predictors of survival in BLCA patients. Based on the calibration curve, our risk signature nomogram was confirmed as a good predictor of BLCA patients’ prognosis at 1, 3, and 5 years. The association analysis of RS and immunotherapy indicated that low-risk patients were more credible for novel immune checkpoint inhibitors (ICI) immunotherapy. The chemotherapeutic drug model suggests that RS has an effect on the drug sensitivity of patients.Conclusions: In conclusion, the eosinophil-based RS can be used as a reliable clinical predictor and provide insights into the precise treatment of BLCA.

Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma

“…We explored the association of risk signature and TMB in this study and found that risk signature and TMB had some synergistic effects in predicting patient survival. Previous studies have found that TMB can be used to predict the efficacy of immune checkpoint inhibitor therapy ( Snyder et al, 2014 ; Hugo et al, 2016 ; Carbone et al, 2017 ; Liang et al, 2021 ; Xu et al, 2022a ; Xu et al, 2022b ). It has also been found that TMB is associated with the prognosis of diffuse glioma ( Wang et al, 2020 ).…”

Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation

“…To determine if there was a correlation between RS and TICs, we measured immune cell infiltration in TME using seven different methods including XCELL, TIMER, QUANTISEQ, MCPcounter, EPIC, CIBERSORT, and CIBERSORT-ABS to evaluate the immune infiltrating situation ( Xu et al, 2022b ). Based on gene expression data, the ESTIMATE algorithm determines how many stromal cells and immune cells are present in a tumor sample using the stromal score and immune score.…”

IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma

“…Subsequently, we used a variety of sources to analyze the correlation between IMPDH1 and immune cells in TME. Immune cells are able to regulate and predict the process of immunotherapy through related hub genes, including a variety of immune cells in the process of tumor immunity, such as CD8 + T cells, tumor-associated macrophages, natural killer cells, eosinophils, etc (41)(42)(43). The strongest relationship suggested that IMPDH1 might play an immunoregulatory role through CD8 + T lymphocytes and monocyte-macrophages.…”